Product Code: GVR-1-68038-913-5
Electrodes For Medical Devices Market Growth & Trends:
The global electrodes for medical devices market size is expected to reach USD 3.42 billion by 2030, according to a new report by Grand View Research, Inc.. It is expected to expand at a CAGR of 11.2% from 2023 to 2030 The market is anticipated to witness lucrative growth during the forecast period, owing to increasing prevalence of chronic and other diseases such as heart diseases, Parkinson's Disease (PD), Alzheimer's disease, brain disorders, Trigeminal Neuralgia (TN or TGN), sinusitis, tinnitus, Raynaud's disease, fibromyalgia, circulatory disturbances, gout, and body ache, across the globe.
Minimally Invasive Surgery (MIS) is one of the advancements in medical technology in which small incisions are made in the body for laparoscopy, endoscopy, arthroscopy, and other surgical procedures. This procedure is gaining popularity owing to faster recovery, lesser postsurgical infections, pain, & major bleeding, reduced scarring, and high accuracy benefits. In 2015, over 20.0 million Americans underwent MIS, which is expected to assist in the growth of this vertical during the forecast period.
Electrodes For Medical Devices Market Report Highlights:
- The diagnostics segment dominated the market in 2022. There has been an increase in the number of cardiovascular, neurological, and sleep disorders in the last few years, which has led to an increase in the number of diagnostics procedures being carried out around the world.
- Rising prevalence of heart diseases, fetal distress syndrome, ocular diseases, and neurological disorders make extensive use of Electrocardiogram (ECG), Electroencephalogram (EEG), electrosurgical, and fetal scalp electrodes
- The therapeutics segment is expected to grow at the fastest CAGR during the forecasted period. The therapeutics segment is further classified into pacemakers, Transcutaneous Electrical Nerve Stimulators (TENS), defibrillators, electrosurgical, and others.
- Defibrillator and electrosurgical electrodes are projected to hold substantial market share over the forecast period. This can be attributed to the advanced development of wearable defibrillator that constantly monitors the cardiac rhythms of the wearer and identifies & notifies the user about the occurrence of any abnormality and helps regain the normal heart functionality
- North America held the largest revenue share of 42.8% in 2022 due to the increasing prevalence of CVD in the region, the changing lifestyle of individuals, health awareness among people, and the presence of the target audience in the U.S. and Canada.
- Asia Pacific is expected to grow at the fastest CAGR of 12.7% over the forecast period. This can be attributed to the presence of chronic diseases in the region, government initiatives regarding health awareness & surge in investment in the healthcare sector.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Type
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Source
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Electrodes for Medical Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.3.3. Industry challenges
- 3.4. Electrodes for Medical Devices Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Electrodes for Medical Devices: Type Estimates & Trend Analysis
- 4.1. Electrodes for Medical Devices Market, Key Takeaways
- 4.2. Electrodes for Medical Devices Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Diagnostics
- 4.3.1. Diagnostics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.1. Electrocardiogram (ECG)
- 4.3.1.1.1. Electrocardiogram (ECG) market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.2. Electroencephalogram (EEG)
- 4.3.1.2.1. Electroencephalogram (EEG) market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.3. Electromyogram (EMG)
- 4.3.1.3.1. Electromyogram (EMG) market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.4. Electroretinogram (ERG)
- 4.3.1.4.1. Electroretinogram (ERG) market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.5. Fetal Scalp
- 4.3.1.5.1. Fetal Scalp market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.1.6. Others
- 4.3.1.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Therapeutics
- 4.4.1. Therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.1. Pacemaker
- 4.4.1.1.1. Pacemaker market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.2. Transcutaneous electrical nerve stimulator
- 4.4.1.2.1. Transcutaneous electrical nerve stimulator market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.3. Defibrillator
- 4.4.1.3.1. Defibrillator market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.4. Electrosurgical
- 4.4.1.4.1. Electrosurgical market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.1.5. Other
- 4.4.1.5.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Electrodes for Medical Devices Market: Regional Estimates & Trend Analysis
- 5.1. Regional Outlook
- 5.2. Electrodes for Medical Devices Market by Region: Key Takeaway
- 5.3. North America
- 5.3.1. U.S.
- 5.3.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.3.2. Canada
- 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4. Europe
- 5.4.1. UK
- 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.2. Germany
- 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.3. France
- 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.4. Italy
- 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.5. Spain
- 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.6. Sweden
- 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.7. Norway
- 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.4.8. Denmark
- 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5. Asia Pacific
- 5.5.1. Japan
- 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.2. China
- 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.3. India
- 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.4. Australia
- 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.5. Thailand
- 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.5.6. South Korea
- 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6. Latin America
- 5.6.1. Brazil
- 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6.2. Mexico
- 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.6.3. Argentina
- 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7. MEA
- 5.7.1. Saudi Arabia
- 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.2. South Africa
- 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.3. UAE
- 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 5.7.4. Kuwait
- 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Market Participant Categorization
- 6.2.1. 3M
- 6.2.1.1. Company overview
- 6.2.1.2. Financial performance
- 6.2.1.3. Product benchmarking
- 6.2.1.4. Strategic initiatives
- 6.2.2. Boston Scientific Corporation
- 6.2.2.1. Company overview
- 6.2.2.2. Financial performance
- 6.2.2.3. Product benchmarking
- 6.2.2.4. Strategic initiatives
- 6.2.3. GE Healthcare
- 6.2.3.1. Company overview
- 6.2.3.2. Financial performance
- 6.2.3.3. Product benchmarking
- 6.2.3.4. Strategic initiatives
- 6.2.4. Medtronic
- 6.2.4.1. Company overview
- 6.2.4.2. Financial performance
- 6.2.4.3. Product benchmarking
- 6.2.4.4. Strategic initiatives
- 6.2.5. Natus Medical Incorporated
- 6.2.5.1. Company overview
- 6.2.5.2. Financial performance
- 6.2.5.3. Product benchmarking
- 6.2.5.4. Strategic initiatives
- 6.2.6. Thermo Fisher Scientific Inc
- 6.2.6.1. Company overview
- 6.2.6.2. Financial performance
- 6.2.6.3. Product benchmarking
- 6.2.6.4. Strategic initiatives
- 6.2.7. Koninklijke Philips N.V.
- 6.2.7.1. Company overview
- 6.2.7.2. Financial performance
- 6.2.7.3. Product benchmarking
- 6.2.7.4. Strategic initiatives
- 6.2.8. Natus Medical Incorporated
- 6.2.8.1. Company overview
- 6.2.8.2. Financial performance
- 6.2.8.3. Product benchmarking
- 6.2.8.4. Strategic initiatives
- 6.2.9. X-trodes
- 6.2.9.1. Company overview
- 6.2.9.2. Financial performance
- 6.2.9.3. Product benchmarking
- 6.2.9.4. Strategic initiatives